Key result
Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) is a preferred procedure for high-risk patients requiring repeat surgical aortic valve replacement, though long-term data are limited.
Why the study?
Despite ViV TAVR becoming preferred for high-risk patients needing repeat SAVR, it carries specific risks, long-term prognostic data are limited, and operators often rely on anecdotal experience.
Design
Review
Authors
Loading...
ViV TAVR selection in younger patients warrants caution; leaves open whether redo-SAVR confers superior long-term survival.
ViV TAVR has become the preferred procedure for high-risk patients needing repeat aortic valve replacement, though it carries specific risks like coronary obstruction and valvular thrombosis.
Hameed et al. (2020) conducted a review in High-risk patients requiring repeat surgical aortic valve replacement. Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) was evaluated. Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) is a preferred procedure for high-risk patients requiring repeat surgical aortic valve replacement, though long-term data are limited.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: